= Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.
Forty Seven, Inc. (CIK 0001667633)
Source: SEC EDGAR database • Date: April 30, 2018 • SIC: 2834 • CIK: 2834
Forty Seven, Inc. (CIK 0001667633)
Source: SEC EDGAR database • Date: April 30, 2018 • SIC: 2834 • CIK: 2834
TLC BIOPHARMACEUTICALS (H.K.) LIMITED COMMERCIALIZATION AGREEMENT
Source: SEC EDGAR database • Date: February 6, 2018 • SIC: 2834 • CIK: 2834
TLC BIOPHARMACEUTICALS (H.K.) LIMITED COMMERCIALIZATION AGREEMENT
Source: SEC EDGAR database • Date: February 6, 2018 • SIC: 2834 • CIK: 2834
TLC BIOPHARMACEUTICALS (H.K.) LIMITED COMMERCIALIZATION AGREEMENT
Source: SEC EDGAR database • Date: February 6, 2018 • SIC: 2834 • CIK: 2834
TLC BIOPHARMACEUTICALS (H.K.) LIMITED COMMERCIALIZATION AGREEMENT
Source: SEC EDGAR database • Date: February 6, 2018 • SIC: 2834 • CIK: 2834
TLC BIOPHARMACEUTICALS (H.K.) LIMITED COMMERCIALIZATION AGREEMENT
Source: SEC EDGAR database • Date: February 6, 2018 • SIC: 2834 • CIK: 2834
TLC BIOPHARMACEUTICALS (H.K.) LIMITED COMMERCIALIZATION AGREEMENT
Source: SEC EDGAR database • Date: February 6, 2018 • SIC: 2834 • CIK: 2834
TLC BIOPHARMACEUTICALS (H.K.) LIMITED COMMERCIALIZATION AGREEMENT
Source: SEC EDGAR database • Date: February 6, 2018 • SIC: 2834 • CIK: 2834
TLC BIOPHARMACEUTICALS (H.K.) LIMITED COMMERCIALIZATION AGREEMENT
Source: SEC EDGAR database • Date: February 6, 2018 • SIC: 2834 • CIK: 2834